2012 annual financial data
Oncolytics Biotech 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -706.08%.
Operating income was -36,688,050 CAD and net income was -36,373,521 CAD.
Operating cash flow was -34,255,638 CAD.
Get free Oncolytics Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,851,528 CAD
- Operating income
- -36,688,050 CAD
- Net income
- -36,373,521 CAD
- Operating cash flow
- -34,255,638 CAD